作者: Wiebke Laffers , Ann-Christin Busse , Jens Mahrt , Phuc Nguyen , Andreas O. H. Gerstner
DOI: 10.1007/S00405-014-2984-8
关键词:
摘要: Clinical outcome of patients suffering from head neck squamous cell carcinomas is still poor due to recurrent disease and surgical limitations. There a demand for multimodality approaches new therapeutic options. Hypericin promising phototoxic drug which was investigated its effects on carcinoma cells in vitro. FaDu incubated with or without hypericin were illuminated (450-700 nm, 50,000 lx) different time periods. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide- terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay used score metabolic apoptotic activity. Even after the shortest illumination showed massive reduction metabolism excessive apoptosis. This present even lowest concentration. Cells not affected. These photosensitizing could be suitable clinical application lead development an intraoperative photodynamic therapy carcinomas.